Biotech & Health

Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M

Biotech & Health /

Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction.  Regeneron said it will acquire 23andMe’s genomics service and its bank of 15 million customers’ personal and genetic data as part of the deal. The pharma giant said it plans to use the 23andMe customer data […]

Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M Read More »

Fieldstone Bio is building microbes that can sense everything from TNT to arsenic

Biotech & Health /

The world is awash in data about, well, the world — thanks to satellites and environmental sensors. But there’s still a lot we can’t see, and Fieldstone Bio thinks microbes can change that. “They’ve evolved to sense and respond to information. It’s just trillions of calculations going on at all times all around us,” Brandon

Fieldstone Bio is building microbes that can sense everything from TNT to arsenic Read More »

Sprinter Health raises $55M to expand its at-home healthcare service

Biotech & Health /

When Max Cohen and Cameron Behar set out to launch a startup together during the pandemic, they decided to focus on the most top-of-mind sector of the era: healthcare. But since neither Cohen nor Behar had a background in healthcare (both worked at Google and Facebook previously), they had to think long and hard about

Sprinter Health raises $55M to expand its at-home healthcare service Read More »

Radiologists aren’t going anywhere | TechCrunch

Biotech & Health /

Nine years ago, AI pioneer Geoffrey Hinton sent shock waves through medicine by declaring it “just completely obvious” that AI would make radiologists extinct in short order. Fast-forward and the specialists — who do more than analyze images — are thriving, observes The New York Times. In fact, the field is experiencing explosive growth amid

Radiologists aren’t going anywhere | TechCrunch Read More »

23andMe customers notified of bankruptcy and potential claims — deadline to file is July 14

Biotech & Health /

23andMe, the genetic testing giant once valued in the billions, is now navigating Chapter 11 bankruptcy and notifying millions of current and former customers that they may be eligible to file claims as part of the restructuring process. The company and 11 of its subsidiaries, including Lemonaid Health and LPRXOne, filed for bankruptcy protection on

23andMe customers notified of bankruptcy and potential claims — deadline to file is July 14 Read More »

Fitness tracker Whoop faces unhappy customers over upgrade policy

Biotech & Health /

Whoop has backed down, somewhat, from the controversial upgrade plans around its Whoop 5.0 fitness tracker. When the company first announced Whoop 5.0 this week, it said members who wanted the new device could either extend their subscriptions by 12 months or pay a one-time upgrade fee of $49 ($79 for the model with EKG

Fitness tracker Whoop faces unhappy customers over upgrade policy Read More »

Elizabeth Holmes’ partner reportedly fundraising for new blood-testing startup

Biotech & Health /

Billy Evans, partner of Theranos founder Elizabeth Holmes, is working on a new startup that seeks to deliver “human health optimization” through blood testing, according to The New York Times. The Times reportedly spoke to two investors pitched on the startup, called Haemanthus, and also viewed some of Haemanthus’ marketing materials. In those materials, the

Elizabeth Holmes’ partner reportedly fundraising for new blood-testing startup Read More »

Meta’s speeding up the ‘Mad Men to Math Men’ pipeline

Biotech & Health /

At Stripe’s Sessions conference this week, Mark Zuckerberg pitched what he calls the “ultimate business machine”: a fully automated, end-to-end AI ad engine promising to replace agencies, creatives, and media buyers with a single black box. You just need to connect your bank account first.  Zuckerberg claims this could be one of the most valuable

Meta’s speeding up the ‘Mad Men to Math Men’ pipeline Read More »

Why Hims & Hers turned to the autonomous vehicle industry to find an AI-savvy CTO

Biotech & Health /

Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief technology officer. The move, according to Hims & Hers co-founder and CEO, Andrew Dudum, was intentional. Hims & Hers on Thursday said its next CTO would be Mo Elshenawy, the former president and CTO

Why Hims & Hers turned to the autonomous vehicle industry to find an AI-savvy CTO Read More »

OpenAI and the FDA are reportedly discussing AI for drug evaluations

Biotech & Health /

OpenAI has met with officials from the U.S. Food and Drug Administration to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the report, OpenAI and the FDA have discussed a project called cderGPT, which seems to be an AI tool for the Center for Drug Evaluation

OpenAI and the FDA are reportedly discussing AI for drug evaluations Read More »